Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.

Source: Fountou-lakis, S., et al. 2015 - Pubmed ID: 26188234

Setting: Greece, Hospital

Study design:



Follow up: 12 months

Patient group:

Sample size:

Total: 115 (105)

IG: 76 (70)

CG: 39 (35)


Inclusion criteria:

  • Diabetes 1 +2
Type of technology:

Home monitoring

  • Glucometer
  • USB connected modem (datatransfer)


  • Telecommunication

Intervention: Pt. transmit data every day. An endocrinologist reviewed the data and contacted participants via mobile phone SMS or e-mails when necessary. Alerts were set for high or low glucose levels. When alerts were activated, the endocrinologist received a text-message thus allowing prompt communication and proper therapeutic adjustments.

6 months

Add on:


Control group: Bimonthly care as provided by outpatient department endocrinologists

Clinical effect/ Patient safety:

Clinical effect:

  • HbA1c ↓
  • BMI →
  • Freq. glucose measurement →
  • Hypoglycemia↓


Patient safety: NA

Patient experiences/ Staff experiences:

Patient experiences:  NA

Staff experiences:
Mean time dedicated per IG patient per month: 10 min

Costs and organization:



  • Blood glucose


  • Staff for monitoring clinical data and for contacting patients

Organization: NA

Health care utilization: NA

Scroll to Top


“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)